Publications by authors named "Benjamin Gartrel"
J Immunother Cancer
February 2023
Article Synopsis
- The study investigates the effectiveness and safety of combining durvalumab (a PD-L1 inhibitor) with radiation therapy in patients with unresectable bladder cancer who cannot receive cisplatin.
- Results showed that after treatment, 72.7% of patients experienced disease control, and 54.5% had a complete response, with a 1-year progression-free survival rate of 71.5%.
- The therapy was generally well tolerated, though some patients experienced significant side effects, but there was no correlation found between outcomes and PD-L1 status of the tumors.
